Reproducibility of retinol binding protein 4 and omentin-1 measurements over a four months period: A reliability study in a cohort of 207 apparently healthy participants

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Wittenbecher, Clemens ^a,b   Di Giuseppe, Romina ^a   Biemann, Ronald ^c   Menzel, Juliane ^a   Arregui, Maria ^a   Hoffmann, Juliane ^c   Aleksandrova, Krasimira ^a   Boeing, Heiner ^a   Isermann, Berend ^c   Schulze, Matthias B ^a,b   Weikert, Cornelia ^a,d  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; EDETIC ACID; OMENTIN 1; RETINOL BINDING PROTEIN 4; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN; PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, HUMAN;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GERMANY; HUMAN; MALE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RELIABILITY; REPRODUCIBILITY; SEX DIFFERENCE; AGED; BLOOD; MIDDLE AGED; NORMAL HUMAN;

ADULT; AGED; BIOMARKERS; COHORT STUDIES; CYTOKINES; FEMALE; GERMANY; GPI-LINKED PROTEINS; HEALTHY VOLUNTEERS; HUMANS; LECTINS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETINOL-BINDING PROTEINS, PLASMA;

EID: 84946924416     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138480     Document Type: Article

References (28)

1. Tsuji S, Uehori J, Matsumoto M, Suzuki Y, Matsuhisa A, Toyoshima K, et al. Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall. The Journal of biological chemistry. 2001; 276(26):23456-63. Epub 2001/04/21. doi: 10.1074/jbc.M103162200 PMID: 11313366.
2. Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC, et al. Identification of omentin as a novel depotspecific adipokine in human adipose tissue: possible role in modulating insulin action. American journal of physiology Endocrinology and metabolism. 2006; 290(6):E1253-61. Epub 2006/03/15. doi: 10.1152/ajpendo.00572.2004 PMID: 16531507.
3. Onur I, Oz F, Yildiz S, Oflaz H, Sigirci S, Elitok A, et al. Serum omentin 1 level is associated with coronary artery disease and its severity in postmenopausal women. Angiology. 2014; 65(10):896-900. Epub 2013/11/23. doi: 10.1177/0003319713511322 PMID: 24265251.
4. Greulich S, Chen WJ, Maxhera B, Rijzewijk LJ, van der Meer RW, Jonker JT, et al. Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies. PloS one. 2013; 8 (3):e59697. Epub 2013/04/05. doi: 10.1371/journal.pone.0059697 PMID: 23555749; PubMed Central PMCID: PMCPMC3612072.
5. Pan HY, Guo L, Li Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes research and clinical practice. 2010; 88(1):29-33. Epub 2010/02/05. doi: 10.1016/j.diabres.2010.01. 013 PMID: 20129687.
6. de Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes. 2007; 56(6):1655-61. Epub 2007/03/03. doi: 10. 2337/db06-1506 PMID: 17329619.
7. Berry DC, Noy N. Signaling by vitamin A and retinol-binding protein in regulation of insulin responses and lipid homeostasis. Biochimica et biophysica acta. 2012; 1821(1):168-76. Epub 2011/07/26. doi: 10.1016/j.bbalip.2011.07.002 PMID: 21782034; PubMed Central PMCID: PMC3204314.
8. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005; 436(7049):356-62. Epub 2005/07/22. doi: 10.1038/nature03711 PMID: 16034410.
9. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Schleicher E, et al. High circulating retinolbinding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans. Diabetes care. 2007; 30(5):1173-8. Epub 2007/01/30. doi: 10.2337/dc06-2342 PMID: 17259477.
10. Hermsdorff HH, Zulet MA, Puchau B, Martinez JA. Central adiposity rather than total adiposity measurements are specifically involved in the inflammatory status from healthy young adults. Inflammation. 2011; 34(3):161-70. Epub 2010/05/15. doi: 10.1007/s10753-010-9219-y PMID: 20467889.
11. Kelly KR, Kashyap SR, O'Leary VB, Major J, Schauer PR, Kirwan JP. Retinol-binding protein 4 (RBP4) protein expression is increased in omental adipose tissue of severely obese patients. Obesity (Silver Spring, Md). 2010; 18(4):663-6. Epub 2009/10/10. doi: 10.1038/oby.2009.328 PMID: 19816414; PubMed Central PMCID: PMCPMC2919818.
12. Rocha M, Banuls C, Bellod L, Rovira-Llopis S, Morillas C, Sola E, et al. Association of serum retinol binding protein 4 with atherogenic dyslipidemia in morbid obese patients. PloS one. 2013; 8(11): e78670. Epub 2013/11/14. doi: 10.1371/journal.pone.0078670 PMID: 24223837; PubMed Central PMCID: PMC3817034.
13. Frey SK, Nagl B, Henze A, Raila J, Schlosser B, Berg T, et al. Isoforms of retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liver. Lipids in health and disease. 2008; 7:29. Epub 2008/08/30. doi: 10.1186/1476-511x-7-29 PMID: 18752671; PubMed Central PMCID: PMCPMC2533662.
14. Henze A, Frey SK, Raila J, Tepel M, Scholze A, Pfeiffer AF, et al. Evidence that kidney function but not type 2 diabetes determines retinol-binding protein 4 serum levels. Diabetes. 2008; 57(12):3323-6. Epub 2008/09/18. doi: 10.2337/db08-0866 PMID: 18796616; PubMed Central PMCID: PMC2584139.
15. Sun L, Qi Q, Zong G, Ye X, Li H, Liu X, et al. Elevated plasma retinol-binding protein 4 is associated with increased risk of type 2 diabetes in middle-aged and elderly Chinese adults. The Journal of nutrition. 2014; 144(5):722-8. Epub 2014/03/22. doi: 10.3945/jn.113.189860 PMID: 24647386.
16. Luft VC, Pereira M, Pankow JS, Ballantyne C, Couper D, Heiss G, et al. Retinol binding protein 4 and incident diabetes-the Atherosclerosis Risk in Communities Study (ARIC Study). Revista brasileira de epidemiologia = Brazilian journal of epidemiology. 2013; 16(2):388-97. Epub 2013/10/22. doi: 10.1590/S1415-790X2013000200014 PMID: 24142010.
17. Sun Q, Kiernan UA, Shi L, Phillips DA, Kahn BB, Hu FB, et al. Plasma retinol-binding protein 4 (RBP4) levels and risk of coronary heart disease: a prospective analysis among women in the nurses' health study. Circulation. 2013; 127(19):1938-47. Epub 2013/04/16. doi: 10.1161/circulationaha.113.002073 PMID: 23584360; PubMed Central PMCID: PMCPMC3741657.
18. Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, et al. STrengthening the Reporting of OBservational studies in Epidemiology-Molecular Epidemiology (STROBE-ME): an extension of the STROBE Statement. PLoS medicine. 2011; 8(10):e1001117. Epub 2011/11/01. doi: 10.1371/journal.pmed.1001117 PMID: 22039356; PubMed Central PMCID: PMC3201942.
19. di Giuseppe R, Hirche F, Montonen J, Buijsse B, Dierkes J, Stangl GI, et al. Reliability of plasma fibroblast growth factor 23 as risk biomarker in epidemiological studies measured over a four-month period. Annals of clinical biochemistry. 2012; 49(Pt 6):542-5. Epub 2012/09/25. doi: 10.1258/acb.2012. 011273 PMID: 23002133.
20. Rosner B. Fundamentals of biostatistics: Cengage Learning; 2010. 606-18 p.
21. Rosner B, Willett WC, Spiegelman D. Correction of logistic regression relative risk estimates and confidence intervals for systematic within-person measurement error. Statistics in medicine. 1989; 8 (9):1051-69; discussion 71-3. PMID: 2799131.
22. Luque-Ramirez M, Martinez-Garcia MA, Montes-Nieto R, Fernandez-Duran E, Insenser M, Alpanes M, et al. Sexual dimorphism in adipose tissue function as evidenced by circulating adipokine concentrations in the fasting state and after an oral glucose challenge. Human reproduction (Oxford, England). 2013; 28(7):1908-18. Epub 2013/04/06. doi: 10.1093/humrep/det097 PMID: 23559188.
23. Lin CJ, Chu NF, Hung YJ, Chang JB, He CT, Hsiao FC, et al. The association of retinol-binding protein 4 with metabolic syndrome and obesity in adolescents: the effects of gender and sex hormones. Clinical pediatrics. 2013; 52(1):16-23. Epub 2012/09/13. doi: 10.1177/0009922812459948 PMID: 22967812.
24. Gavi S, Qurashi S, Stuart LM, Lau R, Melendez MM, Mynarcik DC, et al. Influence of age on the association of retinol-binding protein 4 with metabolic syndrome. Obesity (Silver Spring, Md). 2008; 16 (4):893-5. Epub 2008/02/02. doi: 10.1038/oby.2007.138 PMID: 18239568.
25. Chiba M, Saitoh S, Ohnishi H, Akasaka H, Mitsumata K, Furukawa T, et al. Associations of metabolic factors, especially serum retinol-binding protein 4 (RBP4), with blood pressure in Japanese-the Tanno and Sobetsu study. Endocrine journal. 2010; 57(9):811-7. Epub 2010/08/28. PMID: 20798476.
26. Rothman KJ, Greenland S, Lash TL. Modern epidemiology: Wolters Kluwer Health; 2008.
27. Henze A, Frey SK, Raila J, Scholze A, Spranger J, Weickert MO, et al. Alterations of retinol-binding protein 4 species in patients with different stages of chronic kidney disease and their relation to lipid parameters. Biochemical and biophysical research communications. 2010; 393(1):79-83. Epub 2010/01/26. doi: 10.1016/j.bbrc.2010.01.082 PMID: 20097162.
28. Graham TE, Wason CJ, Bluher M, Kahn BB. Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects. Diabetologia. 2007; 50 (4):814-23. Epub 2007/02/13. doi: 10.1007/s00125-006-0557-0 PMID: 17294166.